Peptides that Stimulate Subcutaenouse Adipogenesis
|
patent-application
|
June 2014 |
Nucleic Acid and Corresponding Protein Entitled 121P1F1 Useful in Treatment and Detection of Cancer
|
patent-application
|
December 2003 |
Hyaluronan Accumulates With High-Fat Feeding and Contributes to Insulin Resistance
|
journal
|
January 2013 |
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance
|
journal
|
July 2013 |
Modulation of Rhamm (CD168) for Selective Adipose Tissue Development
|
patent-application
|
June 2010 |
Method of Inhibiting Human Metapneumovirus and Human Coronavirus in Prevention and Treatment of Severe Acute Respiratory Syndrome (SARS)
|
patent-application
|
November 2004 |
Modulation of Rhamm (CD168) for selective adipose tissue development
|
patent
|
May 2014 |
Methods for the differentiation of human preadipocytes into adipocytes
|
patent
|
November 2000 |
Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset
|
journal
|
April 2014 |
Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
|
patent
|
January 2012 |
Preadipocyte Cell Strains and Uses Therefore
|
patent-application
|
January 2005 |
New Immunosuppressants: Testing and Development in Animal Models and the Clinic: with Special Reference to DSG
|
journal
|
December 1993 |
The Extracellular Signal-Regulated Kinase Isoform ERK1 Is Specifically Required for In Vitro and In Vivo Adipogenesis
|
journal
|
January 2005 |
Hyaluronan receptor protein
|
patent
|
August 2002 |
Method and System for Preparing Soft Tissue for Grafting, Enhancing Grafting Results, and Grafting Autologous Fat and Adipocyte Derived Stem Cells to Soft Tissue Such as the Breast and Other Tissue Defects
|
patent-application
|
December 2009 |
Ace-inhibitory Peptides from Whey and Methods for Providing Same
|
patent-application
|
April 2010 |
Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes
|
journal
|
January 1993 |
Interactions of peptide mimics of hyaluronic acid with the receptor for hyaluronan mediated motility (RHAMM)
|
journal
|
October 2004 |
Fibroblasts require protein kinase C activation to respond to hyaluronan with increased locomotion
|
journal
|
June 2001 |
Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury: Enhancing wound healing with stem cells
|
journal
|
May 2006 |
Adipogenic differentiation of human mesenchymal stem cells
|
patent
|
March 2004 |
The mechanics of hyaluronic acid/adipic acid dihydrazide hydrogel: Towards developing a vessel for delivery of preadipocytes to native tissues
|
journal
|
December 2013 |
Anti-arthropod Vector Vaccines Method of Selecting and Uses Thereof
|
patent-application
|
September 2004 |
Tumor-associated Antigen RHAMM
|
patent-application
|
September 2003 |
Method and Device for Identifying Substances Capable of Modulating Adipocyte Differentiation
|
patent-application
|
February 2005 |
Hyaluronan receptor expression increases in fetal excisional skin wounds and correlates with fibroplasia
|
journal
|
July 1998 |
A RHAMM Mimetic Peptide Blocks Hyaluronan Signaling and Reduces Inflammation and Fibrogenesis in Excisional Skin Wounds
|
journal
|
October 2012 |
N-substituted Heterocycles for the Treatment of Hypercholesteremia, Dyslipidemia and other Metabolic Disorders; Cancer, and other Diseases
|
patent-application
|
July 2003 |
Purification of a hyaluronate-binding protein fraction that modifies cell social behavior
|
journal
|
October 1982 |
Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
|
patent-application
|
August 2018 |
-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds
|
journal
|
April 2002 |
Bioinspired synthesis of self-assembled calcium phosphate nanocomposites using block copolymer-peptide conjugates
|
journal
|
December 2008 |
Signaling Properties of Hyaluronan Receptors
|
journal
|
February 2002 |
Compositions and Methods for Treating Cellular Response to Injury and Other Proliferating Cell Disorders Regulated by Hyaladherin and Hyaluronans
|
patent-application
|
May 2003 |
Method of Inducing Differentiation from Visceral Preadipocyte to Visceral Adipocyte
|
patent-application
|
July 2009 |
Methods and compositions for modulating adipocyte function
|
patent
|
August 2009 |
Rhamm−/− fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair
|
journal
|
December 2006 |
Human Hyaluronan Receptor
|
patent-application
|
January 2004 |
Hyperglycemia Diverts Dividing Osteoblastic Precursor Cells to an Adipogenic Pathway and Induces Synthesis of a Hyaluronan Matrix That Is Adhesive for Monocytes
|
journal
|
April 2014 |
The Role of Ghrelin and Growth Hormone Secretagogues Receptor on Rat Adipogenesis
|
journal
|
March 2003 |
Compositions Affecting Hyaluronic Acid Mediated Activity
|
patent-application
|
November 2010 |
Methods of identifying adipocyte specific genes, the genes identified, and their uses
|
patent-application
|
November 2011 |
Inhibitors of formation of protease resistant prion protein
|
patent
|
April 2001 |
RHAMM Is a Centrosomal Protein That Interacts with Dynein and Maintains Spindle Pole Stability
|
journal
|
June 2003 |
RHAMM Promotes Interphase Microtubule Instability and Mitotic Spindle Integrity through MEK1/ERK1/2 Activity*
|
journal
|
August 2010 |
Self-assembling peptide amphiphiles and related methods for growth factor delivery
|
patent
|
June 2009 |
Antidiabetic Screening of Commercial Botanical Products in 3T3-L1 Adipocytes and db/db Mice
|
journal
|
June 2010 |
Cell Penetrating Peptides
|
patent-application
|
September 2008 |
Interferon-inducible Protein-10 (IP-10 or CXCL10) Chemokine Analogs for the Treatment of Human Diseases
|
patent-application
|
May 2007 |
The influence of the microenvironment on the malignant phenotype
|
journal
|
August 2000 |
TTLL4 Peptides and Vaccines Containing the Same
|
patent-application
|
August 2013 |
Adipocyte Differentiation-associated Gene and Protein
|
patent-application
|
July 2005 |
Assembly of Cell Culture Vessels
|
patent-application
|
December 2009 |
Enhanced affinity hyaluronan binding peptides
|
patent
|
August 2001 |
Hyaluronan: from extracellular glue to pericellular cue
|
journal
|
July 2004 |
Of Mice and Not Men: Differences between Mouse and Human Immunology
|
journal
|
February 2004 |
MHC Multimers in Tuberculosis Diagnostics, Vaccine and Therapeutics
|
patent-application
|
September 2011 |
CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity
|
journal
|
September 1997 |
Tumor-Targeted Hyaluronan Nanoliposomes Increase the Antitumor Activity of Liposomal Doxorubicin in Syngeneic and Human Xenograft Mouse Tumor Models
|
journal
|
July 2004 |
The Hyaluronan Receptor RHAMM Regulates Extracellular-regulated Kinase
|
journal
|
May 1998 |
Vaccinia Virus Polypeptides
|
patent-application
|
March 2012 |
RHAMM/CD168-R3 Peptide Vaccination of HLA-A2+ Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Multiple Myeloma (MM).
|
journal
|
November 2005 |
Compositions and Methods for Treating Cellular Response to Injury and Other Proliferating Cell Disorders Regulated by Hyaladherin and Hyalurons
|
patent-application
|
March 2005 |
Rhamm Peptide Conjugates
|
patent-application
|
February 2004 |
TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan.
|
journal
|
November 1993 |
Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM.
|
journal
|
April 1993 |
Compositions and Methods for Analyzing Renal Cancer
|
patent-application
|
December 2007 |
Cosmetic Oral and/or Parenteral Use of Glucosamine Optionally in Combination with at Least One Polyphenol Compound, and Corresponding Composition
|
patent-application
|
December 2010 |
Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages
|
journal
|
August 2006 |
Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation.
|
journal
|
April 1997 |
Identification and characterization of epitopes of the receptor for hyaluronic acid–mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2–positive patients with acute myeloid leukemia
|
journal
|
August 2005 |
RHAMM Antagonist Antibodies
|
patent-application
|
September 2002 |
Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM.
|
journal
|
March 1995 |
Hyaluronan and Hyaluronan Synthases: Potential Therapeutic Targets in Cancer
|
journal
|
February 2005 |
Hyaluronan-dependent pericellular matrix☆
|
journal
|
November 2007 |
ANKRD26 and Its Interacting Partners TRIO, GPS2, HMMR and DIPA Regulate Adipogenesis in 3T3-L1 Cells
|
journal
|
May 2012 |
Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
|
journal
|
March 2008 |
Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors
|
journal
|
February 1999 |
Modulation of Rhamm-Caveolin/lipid Raft Interactions to Affect Development, Responses to Tissue Injury, Angiogenesis, Tumorigenesis, Metastasis and Growth Factor/cytokine Responses
|
patent-application
|
August 2007 |
A functional role for the p62–ERK1 axis in the control of energy homeostasis and adipogenesis
|
journal
|
February 2010 |
A Role for Hyaluronan in Macrophage Accumulation and Collagen Deposition after Bleomycin-Induced Lung Injury
|
journal
|
October 2000 |
Rhamm, a Co-receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations
|
patent-application
|
March 2010 |
Cell Culture Screen for Agents That Control Adipogenisis and Myofibroblast Differentiation
|
patent-application
|
October 2013 |
Anti-tnfα therapy is useful in rheumatoid arthritis and crohn’s disease: analysis of the mechanism of action predicts utility in other diseases
|
journal
|
December 1998 |
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
|
journal
|
June 1992 |
MAP kinases and cell migration
|
journal
|
September 2004 |
The future of wound healing: Pursuing surgical models in transgenic and knockout mice
|
journal
|
October 2004 |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
patent
|
June 2005 |
RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy
|
journal
|
December 2004 |
Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor)
|
journal
|
October 2003 |
Chimeric adenoviral coat protein and methods of using same
|
patent
|
October 2000 |
Adipose-derived stem cell-containing hyaluronic acid/alginate hydrogel improves vocal fold wound healing: AdMSC Hydrogel for Vocal Fold Wound Healing
|
journal
|
October 2013 |
The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments
|
journal
|
November 1999 |
PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair
|
journal
|
January 2004 |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
patent
|
March 2005 |
Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
|
journal
|
January 1994 |
Stretch-induced bladder smooth muscle cell (SMC) proliferation is mediated by RHAMM-dependent extracellular-regulated kinase (erk) signaling
|
journal
|
June 2001 |
Self-assembling Peptide Amphiphiles and Related Methods for Growth Factor Delivery
|
patent-application
|
September 2005 |
The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells
|
journal
|
June 1998 |
Hyaluronan and Homeostasis: A Balancing Act
|
journal
|
February 2002 |
Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation
|
journal
|
July 1995 |
Chronic liver injury, TGF-β, and cancer
|
journal
|
December 2001 |
Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis
|
journal
|
October 2003 |
Unconventional Secretory Routes: Direct Protein Export Across the Plasma Membrane of Mammalian Cells
|
journal
|
August 2005 |
Bloodstream Cells Phenotypically Identical to Human Mesenchymal Bone Marrow Stem Cells Circulate in Large Amounts Under the Influence of Acute Large Skin Damage: New Evidence for Their Use in Regenerative Medicine
|
journal
|
April 2006 |
Antiviral Agents for the Treatment, Control and Prevention of Infections by Coronavirus
|
patent-application
|
August 2007 |
Development of a Peptide Inhibitor of Hyaluronan-Mediated Leukocyte Trafficking
|
journal
|
September 2000 |
Sesquiterpenoid Derivatives Having Adipocyte Differentiation Inhibitory Effect
|
patent-application
|
March 2005 |